0001850902-24-000009.txt : 20240227
0001850902-24-000009.hdr.sgml : 20240227
20240227162138
ACCESSION NUMBER: 0001850902-24-000009
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220815
FILED AS OF DATE: 20240227
DATE AS OF CHANGE: 20240227
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Grossman Paul David
CENTRAL INDEX KEY: 0001401768
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40538
FILM NUMBER: 24687112
MAIL ADDRESS:
STREET 1: 1600 FARADAY AVENUE
CITY: CARLSBAD
STATE: CA
ZIP: 92008
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Alpha Teknova, Inc.
CENTRAL INDEX KEY: 0001850902
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 943368109
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2451 BERT DRIVE
CITY: HOLLISTER
STATE: CA
ZIP: 95023
BUSINESS PHONE: 8316371100
MAIL ADDRESS:
STREET 1: 2451 BERT DRIVE
CITY: HOLLISTER
STATE: CA
ZIP: 95023
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0508
4
2022-08-15
0
0001850902
Alpha Teknova, Inc.
TKNO
0001401768
Grossman Paul David
300 MONTGOMERY STREET
SUITE 1130
SAN FRANCISCO
CA
94104
1
0
0
0
0
Common Stock
2022-08-15
4
P
0
4826
5.1478
A
4826
D
Common Stock
2022-08-16
4
P
0
4386
5.6226
A
9212
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.10 to $5.1765, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Footnote to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.49 to $5.6822, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Footnote to this Form 4.
By: Damon A. Terrill For: Paul David Grossman
2024-02-27